Galapagos NV header image

Galapagos NV

GLPG

Equity

ISIN null / Valor 3542077

NASDAQ (2026-06-04)

USD 28.11+2.18%

Galapagos NV
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Galapagos NV is a biotechnology firm specializing in oncology and the development of CAR-T therapies and biologics. In 2022, the company expanded its capabilities by acquiring CellPoint and AboundBio, thereby establishing comprehensive end-to-end CAR-T development processes. These acquisitions have enabled Galapagos to implement a decentralized T-cell manufacturing platform and utilize advanced fully human antibody technologies, positioning the company to innovate and advance next-generation CAR-T treatments and biologic therapies within the medical field.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-1.78%1Y

-32.2%3Y

-61.8%5Y

Performance

30.1%1Y

29.1%3Y

33.0%5Y

Volatility

1852 M

Market cap (USD)

148,929

Daily traded volume (Shares)

27.4 / 26.99

1 day high/low (USD)

0.00 / 0.00

52 weeks high/low (USD)

01 January, 2022

Dividend ex-date

0.00

Dividend (USD)

0.00%

Dividend yield (p.a.)

0.002022

0.002023

0.002024

Est dividend (USD)

0.00%2022

0.00%2023

0.00%2024

Est dividend yield

10.00

P/E ratio

00.002022

00.002023

00.002024

Est P/E ratio

0.00

EPS (USD)

0.002022

0.002023

0.002024

Est EPS (USD)

Ratings & reviews

0.00

0 votes

Performance:

0.00

Innovation:

0.00

Society:

0.00

Nature:

0.00

EQUITIES OF THE SAME SECTOR

Roche Holding Ltd

Roche Holding Ltd Valor: 1203204

Annual Return

-50%0%+50%

Risk level

110

4.17%CHF 324.60

Option Care Health Inc

Option Care Health Inc Valor: 52359365

Annual Return

-50%0%+50%

Risk level

110

-2.24%USD 20.07

Galenica Ltd.

Galenica Ltd. Valor: 36067446

Annual Return

-50%0%+50%

Risk level

110

1.09%CHF 83.30

Idorsia Ltd

Idorsia Ltd Valor: 36346343

Annual Return

-50%0%+50%

Risk level

110

9.77%CHF 4.45

Alkermes PLC

Alkermes PLC Valor: 13920929

Annual Return

-50%0%+50%

Risk level

110

1.45%USD 43.38

Medacta Group Ltd

Medacta Group Ltd Valor: 46852522

Annual Return

-50%0%+50%

Risk level

110

1.47%CHF 137.80

Denali Therapeutics Inc

Denali Therapeutics Inc Valor: 39149539

Annual Return

-50%0%+50%

Risk level

110

2.44%USD 20.14

SHL Telemedicine Ltd

SHL Telemedicine Ltd Valor: 1128957

Annual Return

-50%0%+50%

Risk level

110

0.00%CHF 1.00

Evolva Holding LTD

Evolva Holding LTD Valor: 126205578

Annual Return

-50%0%+50%

Risk level

110

-13.51%CHF 1.60

Ambu A/S

Ambu A/S Valor: 39639588

Annual Return

-50%0%+50%

Risk level

110

3.21%DKK 66.00

SIX

FactSet

Clearbit

Logos provided by Clearbit